Latest news
Price to earnings forward of Aprea Therapeutics, Inc. – NASDAQ:APRE - TradingViewTradingView · Sun, 09 Aug 2026 04:52:58 GMTAprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026 - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMT